Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2516 (LINC02516) is a human gene that encodes a long non-coding RNA transcript longer than 200 nucleotides, classified as a lincRNA—meaning it is located in the genome between known protein-coding genes and does not overlap any protein-coding locus[1][5][3]. LincRNAs like LINC02516 are known for diverse regulatory functions, including affecting chromatin architecture and transcriptional regulation, often with cell- or tissue-specific expression and activity[3]. However, the precise biological role and significance of LINC02516 itself remain undetermined, as there is currently no published functional characterization, disease association, or established regulatory pathway for this specific lincRNA in humans[1][5]. In summary, Long intergenic non-protein coding RNA 2516 (LINC02516) is a non-coding RNA with potential regulatory functions typical of lincRNAs, but its individual physiological, pathological, or therapeutic significance has not been established in the published literature to date[1][5][3].
Not applicable; no drugs are known to target this lincRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2516 (LINC02516).